title: Are there any better camptothecins than the ones we have?
authors.affiliation: University of Texas Health Science Center at San Antonio, USA.
authors.forename: Chris H
authors.initials: CH
authors.lastname: Takimoto
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology / Q000627:therapeutic use; D002166:Camptothecin / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D019008:Drug Resistance, Neoplasm; D006801:Humans; D000077146:Irinotecan; D010190:Pancreatic Neoplasms / Q000188:drug therapy; D012106:Research / Q000639:trends; D059004:Topoisomerase I Inhibitors
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D059004:Topoisomerase I Inhibitors; C091719:lurtotecan; C080125:9-aminocamptothecin; D000077146:Irinotecan; C079905:rubitecan; C095887:exatecan; D002166:Camptothecin